Insights into direct nose to brain delivery: current status and future perspective.
about
Olfactory deposition of inhaled nanoparticles in humansNanotechnology-based drug delivery systems for the treatment of Alzheimer's diseasePerillyl Alcohol and Its Drug-Conjugated Derivatives as Potential Novel Methods of Treating Brain MetastasesMicrobubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood-brain barrierIntranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative DiseasesBrain Uptake of Neurotherapeutics after Intranasal versus Intraperitoneal Delivery in Mice.Regeneration in the nervous system with erythropoietinBrain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases.Nanoneurotherapeutics approach intended for direct nose to brain delivery.Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.Novel flurbiprofen derivatives with improved brain delivery: synthesis, in vitro and in vivo evaluations.Intranasal Delivery of Recombinant NT4-NAP/AAV Exerts Potential Antidepressant Effect.A brain-targeting lipidated peptide for neutralizing RNA-mediated toxicity in Polyglutamine Diseases.SIRT1 and stem cells: In the forefront with cardiovascular disease, neurodegeneration and cancer.Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting.Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model.Microdialysis pharmacokinetic study of scopolamine in plasma, olfactory bulb and vestibule after intranasal administration.Toxicology Evaluation of Drugs Administered via Uncommon Routes: Intranasal, Intraocular, Intrathecal/Intraspinal, and Intra-Articular.In Situ-Based Gels for Nose to Brain Delivery for the Treatment of Neurological Diseases.Rasagiline-encapsulated chitosan-coated PLGA nanoparticles targeted to the brain in the treatment of parkinson's diseaseTailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa
P2860
Q23913293-A045FE64-67BC-42F1-8ECF-D79CA9632546Q26783306-2C2C5BC7-659A-454E-94B3-95E3A51A9114Q28072442-16812B38-5E00-4AA1-9735-34DE96B900D6Q30427348-D0EBEDE3-9EDA-43A2-A9EB-467D874D8FE1Q35768362-9A5FF2C2-938D-4E2E-9620-B4C8D079234CQ36052412-3B87D319-F365-4FB8-B784-9D92F265416EQ36247651-8E903A36-E6D1-408D-AB7E-B8C1DFFAC311Q37474214-8247EB78-2207-4B6B-9E7C-F15E2DA7C3AFQ38522125-DA75449D-8AA1-4BFF-8794-D60C18A7AFFDQ38741041-BF76AF26-840D-4E65-BCCC-A88920930CA1Q38741052-72E2781F-8E79-4079-9206-F0220389520DQ40929566-89919213-4AF4-4FD2-B78F-B969E3AA4B33Q42121340-990BE02E-2680-404C-BD01-411B23CC848EQ43197576-21931EF5-FD18-4413-8035-1815ED9C7091Q47893114-5C3334D2-D95C-40EE-ACE1-C071FB35B329Q48265111-CDF82DB1-8FBF-4DCC-83C6-1211AED6047BQ48763889-35EB67AB-3EE8-4AE8-A9CE-A7AFCCA95097Q49628598-EF0ED833-7E50-494A-B2D3-7955E56C828BQ53697270-090B9139-4AC6-4DD5-AA6C-1FEC4770CE2DQ57369531-88CD5335-63F6-4D5F-A56D-2F6BE8D8FDF2Q58800789-96BAC444-E8DC-4477-B614-F7E3F3AF740B
P2860
Insights into direct nose to brain delivery: current status and future perspective.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Insights into direct nose to brain delivery: current status and future perspective.
@en
type
label
Insights into direct nose to brain delivery: current status and future perspective.
@en
prefLabel
Insights into direct nose to brain delivery: current status and future perspective.
@en
P2093
P2860
P1433
P1476
Insights into direct nose to brain delivery: current status and future perspective.
@en
P2093
Deepti Mittal
Jasjeet K Sahni
P2860
P356
10.3109/10717544.2013.838713
P407
P577
2013-10-09T00:00:00Z